Table 2. Characteristics of the study population according to their disease severity.
ENT, ear, nose and throat; CRP, C-reactive protein.
| Non-severe COVID-19N = 101 | Severe COVID-19 N = 44 | P-value | |
|---|---|---|---|
| Demographics | |||
| Age, years, Median (IQR) | 40 (26–57) | 63 (53.5–72) | 0.000 |
| Male, N (%) | 40 (39.6) | 35 (79.55) | 0.000 |
| Comorbidities | |||
| Hypertension, N (%) | 17 (16.83) | 19 (43.18) | 0.001 |
| Diabetes, N (%) | 8 (7.92) | 10 (22.73) | 0.025 |
| Cardiovascular disease, N (%) | 5 (4.95) | 11 (25.00) | 0.001 |
| Respiratory disease, N (%) | 7 (6.93) | 7 (15.91) | 0.125 |
| Other disease, N (%) | 15 (14.85) | 16 (36.36) | 0.007 |
| Clinical symptoms | |||
| Fever, N (%) | 38 (37.62) | 24 (54.55) | 0.069 |
| General symptom, N (%) | 35 (34.65) | 21 (47.73) | 0.144 |
| Respiratory symptom, N (%) | 47 (46.53) | 35 (79.55) | 0.000 |
| ENT symptom, N (%) | 32 (31.68) | 10 (22.73) | 0.323 |
| Digestive symptom, N (%) | 22 (21.78) | 12 (27.27) | 0.525 |
| Blood routine | |||
| Leucocyte (×109 per L) | 5.93 (4.63–7.27) | 6.62 (5.45–8.15) | 0.074 |
| Neutrophil (×109 per L) | 3.56 (2.28–4.86) | 4.74 (3.4–6.8) | 0.000 |
| Lymphocyte (×109 per L) | 1.73 (1.3–2.25) | 1.02 (0.72–1.36) | 0.000 |
| Monocyte (×109 per L) | 0.46 (0.38–0.59) | 0.49 (0.35–0.7) | 0.658 |
| Eosinophil (×109 per L) | 0.04 (0.01–0.08) | 0.01 (0–0.04) | 0.000 |
| Haemoglobin (g/L) | 137 (130–149) | 141 (123.5–147.5) | 0.636 |
| Platelet (×109 per L) | 232 (194–280) | 210.5 (167–291.5) | 0.398 |
| CRP (mg/L) | 3.4 (1.08–16.7) | 86.4 (21.69–145.8) | 0.000 |
| Outcome | |||
| Death | 0 | 14 (31.82) | 0.000 |